# EDGAR Filing Document

**Accession Number:** 0001848756
**File Stem:** 0001213900-26-031042
**Filing Date:** 2026-3
**Character Count:** 21796
**Document Hash:** 80c0c02e0a312935b2b26f9e8e6fc024
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-031042.hdr.sgml**: 20260319

**ACCESSION NUMBER**: 0001213900-26-031042

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260313

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260319

**DATE AS OF CHANGE**: 20260318

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pyrophyte Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001848756
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40957
- **FILM NUMBER:** 26771013

**BUSINESS ADDRESS:**
- **STREET 1:** 3262 WESTHEIMER RD.
- **STREET 2:** SUITE 706
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77098
- **BUSINESS PHONE:** 281 701 4234

**MAIL ADDRESS:**
- **STREET 1:** 3262 WESTHEIMER RD.
- **STREET 2:** SUITE 706
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77098

?xml version='1.0' encoding='ASCII'?

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): March 13, 2026**

**Pyrophyte Acquisition Corp.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-40957** | **N/A** |
| **(State or incorporation<br> or organization)** | **(Commission File Number)** | **(IRS Employer<br> Identification No.)** |

---

---

| | |
|:---|:---|
| **3262 Westheimer Road**<br> **Suite 706**<br> **Houston, Texas** | **77098** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**(281) 701-4234**

**Registrant's telephone number, including area code**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry into a Material Definitive Agreement.**

On March 13, 2026, Pyrophyte Acquisition Corp., a Cayman Islands exempted company ("***Pyrophyte***"), entered into an amendment "***Amendment No. 5***") to the previously announced business combination agreement, dated November 13, 2023, by and among Pyrophyte, Sio Silica Corporation, an Alberta corporation ("***Sio***"), Snowbank NewCo Alberta ULC, an Alberta unlimited liability corporation and a wholly-owned subsidiary of Pyrophyte ("***Pyrophyte Newco***"), and Sio Silica Incorporated, an Alberta corporation ("***Sio Newco***") (the "***Sio Business Combination Agreement***"), with Sio, Pyrophyte Newco and Sio Newco, pursuant to which the parties agreed to extend the outside date from April 29, 2026 to April 29, 2027. Pursuant to the Sio Business Combination Agreement, pursuant to which, among other things and subject to the terms and conditions contained therein, (i) Pyrophyte will transfer by way of continuation from the Cayman Islands to Alberta in accordance with the Cayman Islands Companies Act (as revised) (the "***Companies Act***") and continue as an Alberta corporation in accordance with the applicable provisions of the *Business Corporations Act* (Alberta) (the "***ABCA***") (such continuation, the "***Domestication***"), (ii) following the Domestication, Pyrophyte will amalgamate with Sio Newco (the "***SPAC Amalgamation***"), with Sio Newco surviving the SPAC Amalgamation ("***Pubco***") in accordance with the terms of a Plan of Arrangement (the "***Plan of Arrangement***"), and (iii) Sio and Pyrophyte Newco will amalgamate (the "***Sio Amalgamation***" and together with the SPAC Amalgamation, the "***Amalgamations***"), with Sio surviving the Sio Amalgamation as a wholly-owned subsidiary of Pubco and such entity will continue the business operations currently undertaken by Sio. The transactions contemplated by the Sio Business Combination Agreement are referred to herein as the "***Sio Business Combination***."

The foregoing description of Amendment No. 5 does not purport to be complete and is qualified in its entirety by the provisions of Amendment No. 5, which is attached as Exhibit 2.1 hereto and is incorporated by reference herein.

***Additional Information about the Sio Business Combination and Where to Find It***

Sio Newco intends to file a registration statement on Form F-4 relating to the Sio Business Combination (the "***Registration Statement***"), which will include a preliminary proxy statement of Pyrophyte and a preliminary prospectus of Sio Newco, and after the Registration Statement is declared effective, Pyrophyte will mail the definitive proxy statement/prospectus relating to the Sio Business Combination to Pyrophyte's shareholders as of a record date to be established for voting on the Sio Business Combination. The Registration Statement, including the proxy statement/prospectus contained therein, will contain important information about the Sio Business Combination and the other matters to be voted upon at the extraordinary general meeting of shareholders of Pyrophyte to, among other things, vote for the Sio Business Combination (the "Pyrophyte Shareholders Meeting"). This communication does not contain all the information that should be considered concerning the Sio Business Combination and other matters and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. Pyrophyte and Sio Newco may also file other documents with the SEC regarding the Sio Business Combination. Pyrophyte's shareholders and other interested persons are advised to read, when available, the Registration Statement, including the preliminary proxy statement/prospectus contained therein, and the amendments thereto and the definitive proxy statement/prospectus and other documents filed in connection with the Sio Business Combination, as these materials will contain important information about Pyrophyte, Sio, Pyrophyte Newco, Pubco and the Sio Business Combination.

Pyrophyte's shareholders and other interested persons will be able to obtain copies of the Registration Statement, including the preliminary proxy statement/prospectus contained therein, the definitive proxy statement/prospectus and other documents filed or that will be filed with the SEC, free of charge, by Pyrophyte and Sio Newco through the website maintained by the SEC at www.sec.gov.

***Participants in Solicitation***

Pyrophyte, Sio, Sio Newco and their respective directors and officers may be deemed participants in the solicitation of proxies of Company shareholders in connection with the Sio Business Combination. More detailed information regarding the directors and officers of Pyrophyte, and a description of their interests in Pyrophyte, is contained in Pyrophyte's filings with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on February 19, 2025, and is available free of charge at the SEC's website at www.sec.gov. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies of Pyrophyte's shareholders in connection with the Sio Business Combination and other matters to be voted upon at the Pyrophyte Shareholders Meeting will be set forth in the Registration Statement for the Sio Business Combination when available.

***Forward-Looking Statements***

This Current Report on Form 8-K includes certain statements that may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "seek," "should," "target," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about the Pyrophyte or Sio's ability to effectuate the Sio Business Combination discussed in this document; the benefits of the Sio Business Combination; the future financial performance of Pubco (which will be the go-forward public company following the completion of the business combination) following the transactions; changes in Sio's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management. These forward-looking statements are based on information available as of the date of this document, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing Pyrophyte, Sio or Pubco's views as of any subsequent date, and none of Pyrophyte, Sio or Pubco undertakes any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Neither Pubco nor Pyrophyte gives any assurance that either Pubco or Pyrophyte will achieve its expectations. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, Pubco's actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: (i) the timing to complete the Sio Business Combination by Pyrophyte's business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by Pyrophyte; (ii) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements relating to the Sio Business Combination; (iii) the outcome of any legal, regulatory or governmental proceedings that may be instituted against Pubco, Pyrophyte, Sio or any investigation or inquiry following announcement of the Sio Business Combination, including in connection with the Sio Business Combination; (iv) the inability to complete the Sio Business Combination due to the failure to obtain approval of Pyrophyte's or Sio's shareholders; (v) Sio's and Pubco's success in retaining or recruiting, or changes required in, its officers, key employees or directors following the Sio Business Combination; (vi) the ability of the parties to obtain the listing of Pubco's common shares and warrants on the New York Stock Exchange or another national securities exchange mutually agreed to in writing by the parties to the Business Combination Agreement upon the closing of the Sio Business Combination; (vii) the risk that the Sio Business Combination disrupts current plans and operations of Sio; (viii) the ability to recognize the anticipated benefits of the Sio Business Combination; (ix) unexpected costs related to the Sio Business Combination; (x) the amount of redemptions by Pyrophyte's public shareholders being greater than expected; (xi) the management and board composition of Pubco following completion of the Sio Business Combination; (xii) limited liquidity and trading of Pubco's securities; (xiii) geopolitical risk and changes in applicable laws or regulations; (xiv) the possibility that Sio or Pyrophyte may be adversely affected by other economic, business, and/or competitive factors; (xv) operational risks; (xvi) litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on Sio's resources; (xvii) the risk that the consummation of the Sio Business Combination is substantially delayed or does not occur; and (xix) other risks and uncertainties indicated from time to time in the Registration Statement, including those under "*Risk Factors*" therein, and in Pyrophyte's other filings with the SEC.

***No Offer or Solicitation***

This communication relates to a Sio Business Combination between Sio and Pyrophyte. This document does not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Sio Business Combination. This document does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any offer, sale or exchange of securities in any state or jurisdiction in which such offer, solicitation, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities will be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibits** |
| 2.1 | [Amendment No. 5 to Business Combination Agreement, dated March 13, 2026.](ea028224001ex2-1.htm) |
| 104 | Cover Page Interactive Data File-Embedded within the inline XBRL document. |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **PYROPHYTE ACQUISITION CORP.** | **PYROPHYTE ACQUISITION CORP.** | **PYROPHYTE ACQUISITION CORP.** |
| Date: March 18, 2026 | By: | /s/ Sten Gustafson | /s/ Sten Gustafson |
|  |  | Name: | Sten Gustafson |
|  |  | Title: | Chief Financial Officer |

---

## Exhibit 2.1

**Exhibit 2.1**

**FIFTH AMENDMENT TO**

**BUSINESS COMBINATON AGREEMENT**

This Fifth Amendment to the Business Combination Agreement (this "<u>Amendment</u>") is made as of this 13<sup>th</sup> day of March 2026, by and among Pyrophyte Acquisition Corp., a Cayman Islands exempted company ("<u>SPAC</u>"), Sio Silica Corporation, an Alberta corporation (the "<u>Company</u>"), Snowbank NewCo Alberta ULC, an Alberta unlimited liability corporation ("<u>NewCo</u>"), and Sio Silica Incorporated, an Alberta corporation ("<u>Sio NewCo</u>" and, together with SPAC, the Company, and NewCo, collectively, the "<u>Parties</u>"). Capitalized terms used but not otherwise defined herein have the meanings set forth in the BCA (as defined below).

**WITNESSETH:**

**WHEREAS**, the Parties entered into that certain Business Combination Agreement, dated November 13, 2023 (the "<u>BCA</u>"), that provides for, among other things, an arrangement under section 193 of the *Business Corporation Act* (Alberta) pursuant to which, by means of the Arrangement, Sio NewCo and SPAC will amalgamate (the "<u>SPAC Amalgamation</u>") at the SPAC Amalgamation Effective Time, with Sio NewCo continuing as the surviving company after the SPAC Amalgamation, followed by an amalgamation of the Company and NewCo (the "<u>Company Amalgamation</u>") at the Company Amalgamation Effective Time, with the Company continuing as the surviving company after the Company Amalgamation.

**WHEREAS**, clause (b) of <u>Section 8.01</u> of the BCA provides that either the Company or SPAC may terminate the BCA if the Company Amalgamation Effective Time shall not have occurred prior to the Outside Date;

**WHEREAS**, the Parties entered into the First Amendment (the "First Amendment") to the BCA on the 12<sup>th</sup> of November, 2024 to extend the Outside Date to December 31, 2024; and

**WHEREAS**, the Parties entered into the Second Amendment (the "Second Amendment") to the BCA on the 31<sup>st</sup> of December, 2024 to extend the Outside Date to April 30, 2025; and

**WHEREAS**, the Parties entered into the Third Amendment (the "Third Amendment") to the BCA on the 11<sup>th</sup> of April, 2025 to extend the Outside Date to December 31, 2025; and

**WHEREAS**, the Parties entered into the Fourth Amendment (the "Third Amendment") to the BCA on the 16<sup>th</sup> of October, 2025 to extend the Outside Date to April 29, 2026; and

**WHEREAS**, the Parties wish to further amend the BCA to further extend the Outside Date; and

**WHEREAS**, <u>Section 8.04</u> of the BCA provides that the BCA may be amended by an instrument in writing signed by each of the Parties at any time prior to the Company Amalgamation Effective Time.

**NOW, THEREFORE,** in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties, being all of the parties to the BCA, hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1. <u>Amendment to the BCA</u>. Effective as of the date of this Amendment:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a. <u>Section 8.01(b)</u> of the BCA is amended and restated in its entirety as provided below:

"(b) by either SPAC or the Company if the Company Amalgamation Effective Time shall not have occurred prior to April 29, 2027 (the "<u>Outside Date</u>"); provided, however, that this Agreement may not be terminated under this Section 8.01(b) by or on behalf of any Party that either directly or indirectly through its Affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained herein and such breach or violation is the principal cause of the failure of a condition set forth in Article VII on or prior to the Outside Date;"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>No Other Amendments</u>. Except as specifically deemed amended as set forth herein, the BCA shall remain in full force and effect in accordance with its terms. The amendments provided in this Amendment shall be applicable solely with respect to those matters expressly provided herein and no other amendments, waivers or consents may be construed or implied. The BCA, the First Amendment, the Second Amendment, the Third Amendment, this Amendment, and the Ancillary Agreements constitute the entire agreement among the Parties, and merge and supersede, except as set forth in Section 6.03(b) of the BCA, all prior and contemporaneous agreements and undertakings, both written and oral, among the Parties, or any of them, with respect to the subject matter hereof and thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Counterparts</u>. This BCA may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Miscellaneous</u>. The provisions of Section 8.04 (Amendment), Section 8.05 (Waiver), Section 9.01 (Notices), Section 9.03 (Severability), Section 9.04 (Assignment), Section 9.06 (Governing Law), Section 9.07 (Waiver of Jury Trial), Section 9.10 (Specific Performance) and Section 9.11 (Non-Recourse) of the BCA shall apply to this Amendment mutatis mutandis.

[SIGNATURE PAGE FOLLOWS]

**IN WITNESS WHEREOF**, the Parties have caused this Amendment to be executed as of the date first written above.

---

| | | |
|:---|:---|:---|
| PYROPHYTE ACQUISITION CORP. | PYROPHYTE ACQUISITION CORP. | PYROPHYTE ACQUISITION CORP. |
| **By:** | /s/ Sten L. Gustafson | /s/ Sten L. Gustafson |
|  | **Name:** | **Sten L Gustafson** |
|  | **Title:** | **President and Chief Financial Officer** |
| SIO SILICA CORPORATION | SIO SILICA CORPORATION | SIO SILICA CORPORATION |
| **By:** | /s/ **Feisal Somji** | /s/ **Feisal Somji** |
|  | **Name:** | **Feisal Somji** |
|  | **Title:** | **CEO** |
| SNOWBANK NEWCO ALBERTA ULC | SNOWBANK NEWCO ALBERTA ULC | SNOWBANK NEWCO ALBERTA ULC |
| **By:** | /s/ **Feisal Somji** | /s/ **Feisal Somji** |
|  | **Name:** | **Feisal Somji** |
|  | **Title:** | **President** |
| SIO SILICA INCORPORATED | SIO SILICA INCORPORATED | SIO SILICA INCORPORATED |
| **By:** | /s/ **Feisal Somji** | /s/ **Feisal Somji** |
|  | **Name:** | **Feisal Somji** |
|  | **Title:** | **President** |

---

[Signature Page to Fifth Amendment to Business Combination Agreement]